{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:12:37Z","timestamp":1740107557428,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00592-021-01763-1","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T17:02:55Z","timestamp":1626454975000},"page":"1665-1672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation"],"prefix":"10.1007","volume":"58","author":[{"given":"Galia","family":"Barash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Bassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayelet","family":"Livne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilach","family":"Benyamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0852-0831","authenticated-orcid":false,"given":"Marianna","family":"Rachmiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"issue":"Suppl. 1","key":"1763_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000053198","volume":"53","author":"JPH Shield","year":"2000","unstructured":"Shield JPH (2000) Neonatal diabetes: new insights into aetiology and implications. Horm Res Paediatr 53(Suppl. 1):7\u201311. https:\/\/doi.org\/10.1159\/000053198","journal-title":"Horm Res Paediatr"},{"key":"1763_CR2","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1126\/science.270.5239.1166","volume":"270","author":"N Inagaki","year":"1995","unstructured":"Inagaki N, Gonoi T, Clement JP et al (1995) Reconstitution of IKATP an inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166\u20131170","journal-title":"Science"},{"key":"1763_CR3","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa032922","volume":"18","author":"AL Gloyn","year":"2004","unstructured":"Gloyn AL, Pearson ER et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 18:1838\u20131887","journal-title":"N Engl J Med"},{"issue":"5","key":"1763_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1056\/NEJMoa055068","volume":"355","author":"AP Babenko","year":"2006","unstructured":"Babenko AP, Polak M, Cav\u00e9 H et al (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus from the departments of molecular and cellular biology. N Engl J Med 355(5):456\u2013466","journal-title":"N Engl J Med"},{"issue":"4","key":"1763_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/emboj\/18.4.833","volume":"18","author":"B Liss","year":"1999","unstructured":"Liss B, Bruns R, Roeper J (1999) Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J 18(4):833\u2013846","journal-title":"EMBO J"},{"key":"1763_CR6","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1073\/pnas.87.9.3489","volume":"87","author":"H Schmid-Antomarchi","year":"1990","unstructured":"Schmid-Antomarchi H, Amoroso S, Fosset M, Lazdunskit M (1990) K+ channel openers activate brain sulfonylurea-sensitive K+ channels and block neurosecretion. Proc Natl Acad Sci USA 87:3489\u20133492","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1763_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/sj.ejhg.5201629","volume":"14","author":"AL Gloyn","year":"2006","unstructured":"Gloyn AL, Diatloff-Zito C, Edghill EL et al (2006) KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 14(7):824\u2013830. https:\/\/doi.org\/10.1038\/sj.ejhg.5201629","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"1763_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00125-003-1143-3","volume":"46","author":"FM Gribble","year":"2003","unstructured":"Gribble FM, Reimann F (2003) Sulphonylurea action revisited: the post-cloning era. Diabetologia 46(7):875\u2013891. https:\/\/doi.org\/10.1007\/s00125-003-1143-3","journal-title":"Diabetologia"},{"issue":"5","key":"1763_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJMoa061759","volume":"355","author":"ER Pearson","year":"2006","unstructured":"Pearson ER, Flechtner I, Njolstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355(5):467\u2013477. https:\/\/doi.org\/10.1056\/NEJMoa061759","journal-title":"N Engl J Med"},{"issue":"7","key":"1763_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/pedi.12447","volume":"18","author":"Y Hashimoto","year":"2017","unstructured":"Hashimoto Y, Dateki S, Hirose M et al (2017) Molecular and clinical features of KATP-channel neonatal diabetes mellitus in Japan. Pediatr Diabetes 18(7):532\u2013539. https:\/\/doi.org\/10.1111\/pedi.12447","journal-title":"Pediatr Diabetes"},{"key":"1763_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2169","author":"KE Snider","year":"2013","unstructured":"Snider KE, Becker S, Boyajian L et al (2013) Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2012-2169","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1763_CR12","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1210\/jc.2009-1137","volume":"94","author":"O Rubio-Cabezas","year":"2009","unstructured":"Rubio-Cabezas O, Patch AM, Minton JAL et al (2009) Wolcott-rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab 94(11):4162\u20134170. https:\/\/doi.org\/10.1210\/jc.2009-1137","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1763_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1399-5448.2011.00824.x","volume":"13","author":"O Rubio-Cabezas","year":"2012","unstructured":"Rubio-Cabezas O, Flanagan SE, Damhuis A, Hattersley AT, Ellard S (2012) KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr Diabetes 13(4):322\u2013325. https:\/\/doi.org\/10.1111\/j.1399-5448.2011.00824.x","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"1763_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2014.03.014","volume":"51","author":"J Wanigasinghe","year":"2014","unstructured":"Wanigasinghe J, Arambepola C, Sri Ranganathan S, Sumanasena S, Muhandiram EC (2014) The efficacy of moderate-to-high dose oral prednisolone versus low-to-moderate dose intramuscular corticotropin for improvement of hypsarrhythmia in west syndrome: a randomized, single-blind, parallel clinical trial. Pediatr Neurol 51(1):24\u201330. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2014.03.014","journal-title":"Pediatr Neurol"},{"issue":"4","key":"1763_CR15","first-page":"291","volume":"16","author":"JV Barone","year":"2011","unstructured":"Barone JV, Tillman EM, Ferry RJ (2011) Treatment of transient neonatal diabetes mellitus with subcutaneous insulin glargine in an extremely low birth weight neonate. J Pediatr Pharmacol Ther 16(4):291\u2013297","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"1763_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00592-015-0828-7","volume":"53","author":"I Rabbone","year":"2016","unstructured":"Rabbone I, Barbetti F, Marigliano M et al (2016) Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis. Acta Diabetol 53(4):559\u2013565. https:\/\/doi.org\/10.1007\/s00592-015-0828-7","journal-title":"Acta Diabetol"},{"key":"1763_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.diabres.2017.04.007","volume":"129","author":"I Rabbone","year":"2017","unstructured":"Rabbone I, Barbetti F, Gentilella R et al (2017) Insulin therapy in neonatal diabetes mellitus: a review of the literature. Diabetes Res Clin Prac 129:126\u2013135. https:\/\/doi.org\/10.1016\/j.diabres.2017.04.007","journal-title":"Diabetes Res Clin Prac"},{"issue":"2","key":"1763_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2337\/dc07","volume":"31","author":"M Rafiq","year":"2008","unstructured":"Rafiq M, Flanagan SE, Patch A-M, Shields BM, Ellard S, Hattersley AT (2008) Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 31(2):204\u2013209. https:\/\/doi.org\/10.2337\/dc07","journal-title":"Diabetes Care"},{"issue":"8","key":"1763_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S2213-8587(18)30106-2","volume":"6","author":"P Bowman","year":"2018","unstructured":"Bowman P, Sulen \u00c5, Barbetti F et al (2018) Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol 6(8):637\u2013646. https:\/\/doi.org\/10.1016\/S2213-8587(18)30106-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1763_CR20","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00125-016-3921-8","volume":"59","author":"T Babiker","year":"2016","unstructured":"Babiker T, Vedovato N, Patel K et al (2016) Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia 59(6):1162\u20131166. https:\/\/doi.org\/10.1007\/s00125-016-3921-8","journal-title":"Diabetologia"},{"issue":"8","key":"1763_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tem.2010.03.004","volume":"21","author":"SAW Greeley","year":"2010","unstructured":"Greeley SAW, Tucker SE, Naylor RN, Bell GI, Philipson LH (2010) Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrinol Metab 21(8):464\u2013472. https:\/\/doi.org\/10.1016\/j.tem.2010.03.004","journal-title":"Trends Endocrinol Metab"},{"key":"1763_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000268488.51776.53","author":"K Shimomura","year":"2007","unstructured":"Shimomura K, H\u00f6rster F, de Wet H et al (2007) A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000268488.51776.53","journal-title":"Neurology"},{"issue":"9","key":"1763_CR23","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","volume":"54","author":"AT Hattersley","year":"2005","unstructured":"Hattersley AT, Ashcroft FM (2005) Perspectives in diabetes activating mutations in Kir6.2 and neonatal diabetes new clinical syndromes, new scientific insights, and new therapy. Diabetes 54(9):2503\u20132513","journal-title":"Diabetes"},{"issue":"10","key":"1763_CR24","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2337\/dc11-2225","volume":"35","author":"RP Shah","year":"2012","unstructured":"Shah RP, Spruyt K, Kragie BC, Greeley SAW, Msall ME (2012) Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas. Diabetes Care 35(10):2086\u20132088. https:\/\/doi.org\/10.2337\/dc11-2225","journal-title":"Diabetes Care"},{"issue":"11","key":"1763_CR25","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2337\/dc15-0837","volume":"38","author":"J Beltrand","year":"2015","unstructured":"Beltrand J, Elie C, Busiah K et al (2015) Sulfonylurea therapy benefits neurological and psychomotor functions in patients with neonatal diabetes owing to potassium channel mutations. Diabetes Care 38(11):2033\u20132041. https:\/\/doi.org\/10.2337\/dc15-0837","journal-title":"Diabetes Care"},{"issue":"3","key":"1763_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","volume":"25","author":"AS Slingerland","year":"2008","unstructured":"Slingerland AS, Hurkx W, Noordam K et al (2008) Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation. Diabetes Med 25(3):277\u2013281. https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02373.x","journal-title":"Diabetes Med"},{"key":"1763_CR27","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1196","author":"LC Gurgel","year":"2007","unstructured":"Gurgel LC, Crispim F, Noffs MHS, Belzunces E, Rahal MA, Mois\u00e9s RS (2007) Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene [1]. Diabetes Care. https:\/\/doi.org\/10.2337\/dc07-1196","journal-title":"Diabetes Care"},{"issue":"3","key":"1763_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/ped.12294","volume":"56","author":"H Oka","year":"2014","unstructured":"Oka H, Suzuki S, Furuya A et al (2014) Glycemic control and motor development in a patient with intermediate DEND. Pediatr Int 56(3):432\u2013435. https:\/\/doi.org\/10.1111\/ped.12294","journal-title":"Pediatr Int"},{"issue":"1","key":"1763_CR29","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.diabres.2014.12.010","volume":"108","author":"S Pe\u00f1a-Almazan","year":"2015","unstructured":"Pe\u00f1a-Almazan S (2015) Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation. Diabetes Res Clin Pract 108(1):e18\u2013e20. https:\/\/doi.org\/10.1016\/j.diabres.2014.12.010","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1763_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2337\/db06-1275","volume":"56","author":"R Masia","year":"2007","unstructured":"Masia R, Koster JC, Tumini S et al (2007) An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Diabetes 56(2):328\u2013336. https:\/\/doi.org\/10.2337\/db06-1275","journal-title":"Diabetes"},{"issue":"10","key":"1763_CR31","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1464-5491.2007.02228.x","volume":"24","author":"Z Sumnik","year":"2007","unstructured":"Sumnik Z, Kolouskova S, Wales JKH, Komarek V, Cinek O (2007) Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome) [7]. Diabet Med 24(10):1176\u20131178. https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02228.x","journal-title":"Diabet Med"},{"key":"1763_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134476","author":"C Lahmann","year":"2015","unstructured":"Lahmann C, Kramer HB, Ashcroft FM (2015) Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0134476","journal-title":"PLoS ONE"},{"key":"1763_CR33","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2017-0155","author":"S Ioacara","year":"2018","unstructured":"Ioacara S, Sava E, Barosan A, Cojocaru F, Gutan A, Fica S (2018) To diet or not to diet in neonatal diabetes responding to sulfonylurea treatment. J Pediatr Endocrinol Metab. https:\/\/doi.org\/10.1515\/jpem-2017-0155","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1763_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000721","author":"P Bowman","year":"2019","unstructured":"Bowman P, McDonald TJ, Knight BA et al (2019) Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K ATP -channel pathways. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000721","journal-title":"BMJ Open Diabetes Res Care."},{"issue":"9","key":"1763_CR35","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1177\/0883073807306272","volume":"22","author":"N Bahi-Buisson","year":"2007","unstructured":"Bahi-Buisson N, Eisermann M, Nivot S et al (2007) Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2. J Child Neurol 22(9):1147\u20131150. https:\/\/doi.org\/10.1177\/0883073807306272","journal-title":"J Child Neurol"},{"key":"1763_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2014.03.014","author":"J Wanigasinghe","year":"2014","unstructured":"Wanigasinghe J, Arambepola C, Sri Ranganathan S, Sumanasena S, Muhandiram EC (2014) The efficacy of moderate-to-high dose oral prednisolone versus low-to-moderate dose intramuscular corticotropin for improvement of hypsarrhythmia in west syndrome: a randomized, single-blind, parallel clinical trial. Pediatr Neurol. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2014.03.014","journal-title":"Pediatr Neurol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01763-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T14:05:58Z","timestamp":1635084358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01763-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01763-1","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"13 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have indicated they have no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}},{"value":"The parents signed a consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}